Abegaill Overview

  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 2

Abegaill General Information


Developer of medical devices designed to treat pre-malignant breast disease. The company's devices can help in investigating for the first signs of breast cancer development, enabling doctors to seamlessly adopt the procedure of ductoscopy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Overwegwachter 4
  • 3034 KG Rotterdam
  • Netherlands
+31 06 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abegaill Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Dec-2017 Completed Startup
To view Abegaill’s complete valuation and funding history, request access »

Abegaill Executive Team (1)

Name Title Board Seat Contact Info
Edwin Leander Chief Executive Officer
To view Abegaill’s complete executive team members history, request access »

Abegaill Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Leander Healthcare B.V. Corporation Minority 000 0000 000000 0
Swanbridge Capital Venture Capital Minority 000 0000 000000 0
To view Abegaill’s complete investors history, request access »